15-min delayed · Sep 9, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 13 firms covering BeiGene, Ltd, 13 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $367.00 to $454.00, so the covering firms are broadly aligned. The average target of $413.60 sits 18% above the current $351.07. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 11 to 13 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.53 next quarter toward $10.28 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 ratings
Strong Buy
Strong Buy00%
Buy13100%
Hold00%
Sell00%
Strong Sell00%
Based on 13 analysts giving stock ratings to BeiGene, Ltd.
As of Sep, 13 of 13 firms rate ONC a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ONC EPS & revenue forecast
EPS · NEXT QUARTER
$1.53
Range $0.87 – $1.91 · 11 analysts · +164% YoY
Next period, 11 analysts expect BeiGene, Ltd. to earn $1.53 a share (range $0.87 – $1.91), versus $0.58 a year earlier. Full-year consensus is $7.60, growing to $10.28 the year after.
REVENUE · NEXT QUARTER
$1.8B
Range $1.7B – $1.8B · 11 analysts · +19% YoY
Revenue is expected to reach $1.8B (range $1.7B – $1.8B), +19.1% year-over-year. Full-year consensus is $6.8B, rising to $7.7B next year.
Top analysts covering BeiGene, Ltd.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ONC.
#1
Michael Schmidt
Guggenheim · Rank #2
Buy
$430.00+22.5% to target
Overall win rate
55%
+ Follow
#2
Leonid Timashev
RBC Capital · Rank #33
Buy
$450.00+28.2% to target
Overall win rate
48%
+ Follow
#3
Jessica Fye
JP Morgan · Rank #71
Buy
$425.00+21.1% to target
Overall win rate
53%
+ Follow
#4
Yigal Nochomovitz
Citigroup · Rank #245
Buy
$466.00+32.7% to target
Overall win rate
41%
+ Follow
#5
Reni J. Benjamin
JMP Securities · Rank #366
Buy
$405.00+15.4% to target
Overall win rate
32%
+ Follow
ONC stock forecast FAQ
What is ONC's average 12-month price target?+
The 9 analysts with a live target average $413.60 for BeiGene, Ltd. over the next 12 months, ranging from a $454.00 high to a $367.00 low.
Is ONC stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 13 analyst ratings, 13 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ONC?+
The Street-high target is $454.00 (TD Cowen), and the Street-low is $367.00. The average of all 9 active targets is $413.60.
How many Wall Street analysts cover ONC?+
13 analysts have an active rating on BeiGene, Ltd., and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering ONC?+
Among analysts who currently cover ONC, Michael Schmidt of Guggenheim has the strongest overall Quantellect track record (Rank #2). Their current call is Buy with a $430.00 target.
What is BeiGene, Ltd.'s projected EPS for next quarter?+
The consensus estimate is $1.53 per share (range $0.87 – $1.91) across 11 analysts. Full-year EPS is projected at $7.60, rising to $10.28 the following year.
How much revenue is BeiGene, Ltd. expected to report next quarter?+
Consensus revenue is $1.8B (range $1.7B – $1.8B). Full-year revenue is projected at $6.8B, growing to $7.7B next year.
Have analysts been upgrading or downgrading ONC lately?+
As of Sep, 13 of 13 firms rate ONC a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ONC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
